Pharmacometric and electrocardiographic evaluation of chloroquine and azithromycin in healthy volunteers
Chloroquine and azithromycin were developed in combination for the preventive treatment of malaria in pregnancy, and more recently were proposed as coronavirus disease 2019 (COVID-19) treatment options. Billions of doses of chloroquine have been administered worldwide over the past 70 years but conc...
主要な著者: | Chotsiri, P, Tarning, J, Hoglund, RM, Watson, JA, White, NJ |
---|---|
フォーマット: | Journal article |
言語: | English |
出版事項: |
American Society for Clinical Pharmacology and Therapeutics
2022
|
類似資料
-
A pharmacometric approach to evaluate drugs for potential repurposing as COVID-19 therapeutics
著者:: Wattanakul, T, 等
出版事項: (2022) -
Population pharmacokinetics and electrocardiographic effects of dihydroartemisinin-piperaquine in healthy volunteers
著者:: Chotsiri, P, 等
出版事項: (2017) -
Concentration-dependent mortality of chloroquine in overdose
著者:: Watson, JA, 等
出版事項: (2020) -
COVID-19 prevention and treatment: A critical analysis of chloroquine and hydroxychloroquine clinical pharmacology
著者:: White, NJ, 等
出版事項: (2020) -
Primaquine in glucose-6-phosphate dehydrogenase deficiency: an adaptive pharmacometric assessment of ascending dose regimens in healthy volunteers
著者:: Pukrittayakamee, S, 等
出版事項: (2024)